St. Jude Medical to Present at the 23rd Annual Piper Jaffray Health Care Conference
November 17 2011 - 4:45PM
Business Wire
St. Jude Medical, Inc. (NYSE:STJ) will present at the 23rd
Annual Piper Jaffray Health Care Conference on Wednesday, November
30, in New York City. John Heinmiller, executive vice president and
chief financial officer, will address the conference at 8:00 a.m.
EST. The presentation will also be Web cast live at
www.sjm.com.
About St. Jude Medical
St. Jude Medical, Inc. develops medical technology and services
that focus on putting more control into the hands of those who
treat cardiac, neurological and chronic pain patients worldwide.
The company is dedicated to advancing the practice of medicine by
reducing risk wherever possible and contributing to successful
outcomes for every patient. St. Jude Medical is headquartered in
St. Paul, Minn. and has four major focus areas that include cardiac
rhythm management, atrial fibrillation, cardiovascular and
neuromodulation. For more information, please visit
www.sjm.com.
Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties. Such forward-looking
statements include the expectations, plans and prospects for the
Company, including potential clinical successes, anticipated
regulatory approvals and future product launches, and projected
revenues, margins, earnings and market shares. The statements made
by the Company are based upon management's current expectations and
are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include
market conditions and other factors beyond the Company's control
and the risk factors and other cautionary statements described in
the Company's filings with the SEC, including those described in
the Risk Factors and Cautionary Statements sections of the
Company's Annual Report on Form 10-K for the fiscal year ended
January 1, 2011 and Quarterly Report on Form 10-Q for the fiscal
quarter ended July 2, 2011. The Company does not intend to update
these statements and undertakes no duty to any person to provide
any such update under any circumstance.
SJM (NYSE:STJ)
Historical Stock Chart
From Sep 2024 to Oct 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Oct 2023 to Oct 2024